Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06565351
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
S-cystatin C vsInjection Clearance Measurements to Estimate Kidney Function in Patients With Spinal Cord Injuries
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Feasibility of Replacing 99mTc-DTPA GFR Measurements With eGFR From s-Cystatin C in Individuals With Spinal Cord Injuries
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In individuals with spinal cord injury SCI kidney function defined as Glomerular Filtration Rate GFR is monitored by injection of eg99mDTPA and subsequent blood sampling DTPA-clearance
GFR calculated from plasma samples of the endogenous substance s-Cystatin C eGFR cystatin C was compared to DTPA-clearance in 248 individuals with SCI
It is concluded that eGFR based on plasma s-cystatin C can replace the more tedious 99mDTPA-clearance procedures in individuals with SCI
GFR calculated from plasma samples of the endogenous substance s-Cystatin C eGFR cystatin C was compared to DTPA-clearance in 248 individuals with SCI
It is concluded that eGFR based on plasma s-cystatin C can replace the more tedious 99mDTPA-clearance procedures in individuals with SCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None